Geode Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.14B Sell
59,558,154
-489,830
-0.8% -$56.6M 0.44% 33
2025
Q4
$6.31B Buy
60,047,984
+249,110
+0.4% +$23.4M 0.39% 34
2025
Q3
$5.01B Buy
59,798,874
+846,193
+1% +$69.7M 0.32% 40
2025
Q2
$4.65B Sell
58,952,681
-704,589
-1% -$56M 0.33% 45
2025
Q1
$5.34B Sell
59,657,270
-1,524,593
-2% -$142M 0.42% 30
2024
Q4
$6.07B Buy
61,181,863
+2,026,859
+3% +$209M 0.47% 26
2024
Q3
$6.7B Buy
59,155,004
+2,134,296
+4% +$254M 0.54% 23
2024
Q2
$7.04B Buy
57,020,708
+609,479
+1% +$78.5M 0.62% 21
2024
Q1
$7.43B Buy
56,411,229
+982,984
+2% +$121M 0.69% 20
2023
Q4
$6.03B Buy
55,428,245
+1,354,125
+3% +$141M 0.63% 20
2023
Q3
$5.56B Buy
54,074,120
+1,350,663
+3% +$146M 0.66% 21
2023
Q2
$6.07B Buy
52,723,457
+1,504,701
+3% +$171M 0.71% 19
2023
Q1
$5.44B Buy
51,218,756
+2,879,481
+6% +$311M 0.71% 18
2022
Q4
$5.35B Buy
48,339,275
+238,356
+0.5% +$24.4M 0.75% 22
2022
Q3
$4.14B Buy
48,100,919
+2,106,251
+5% +$188M 0.63% 23
2022
Q2
$4.19B Buy
45,994,668
+1,587,055
+4% +$141M 0.61% 23
2022
Q1
$3.63B Sell
44,407,613
-3,745,670
-8% -$295M 0.45% 35
2021
Q4
$3.68B Buy
48,153,283
+5,409,154
+13% +$431M 0.44% 38
2021
Q3
$3.2B Sell
42,744,129
-1,465,619
-3% -$111M 0.43% 37
2021
Q2
$3.43B Sell
44,209,748
-617,947
-1% -$46M 0.47% 28
2021
Q1
$3.29B Buy
44,827,695
+704,170
+2% +$51.9M 0.5% 29
2020
Q4
$3.44B Buy
44,123,525
+774,397
+2% +$59.2M 0.58% 25
2020
Q3
$3.42B Buy
43,349,128
+1,334,738
+3% +$105M 0.67% 20
2020
Q2
$3.1B Buy
42,014,390
+223,396
+0.5% +$16.8M 0.66% 20
2020
Q1
$3.06B Sell
41,790,994
-108,476
-0.3% -$8.53M 0.8% 18
2019
Q4
$3.63B Buy
41,899,470
+718,660
+2% +$59M 0.76% 21
2019
Q3
$3.3B Buy
41,180,810
+641,815
+2% +$51.4M 0.77% 20
2019
Q2
$3.24B Buy
40,538,995
+865,579
+2% +$66.3M 0.78% 22
2019
Q1
$3.14B Buy
39,673,416
+4,007,496
+11% +$300M 0.81% 18
2018
Q4
$2.6B Buy
35,665,920
+3,374,432
+10% +$238M 0.8% 21
2018
Q3
$2.18B Buy
32,291,488
+117,197
+0.4% +$7.47M 0.61% 26
2018
Q2
$1.86B Buy
32,174,291
+335,262
+1% +$18.9M 0.57% 29
2018
Q1
$1.65B Buy
31,839,029
+1,324,595
+4% +$71.5M 0.54% 32
2017
Q4
$1.63B Buy
30,514,434
+1,003,625
+3% +$55.6M 0.56% 32
2017
Q3
$1.8B Buy
29,510,809
+610,249
+2% +$37M 0.66% 26
2017
Q2
$1.76B Buy
28,900,560
+2,163
+0% +$132K 0.69% 23
2017
Q1
$1.75B Buy
28,898,397
+2,034,910
+8% +$123M 0.72% 22
2016
Q4
$1.51B Buy
26,863,487
+1,168,982
+5% +$68.4M 0.7% 22
2016
Q3
$1.53B Buy
25,694,505
+1,100,866
+4% +$64.4M 0.77% 19
2016
Q2
$1.35B Sell
24,593,639
-197,885
-0.8% -$10.5M 0.73% 21
2016
Q1
$1.25M Buy
24,791,524
+370,441
+2% +$18.1M 0.66% 26
2015
Q4
$1.23B Sell
24,421,083
-137,699
-0.6% -$6.94M 0.7% 25
2015
Q3
$1.16B Buy
24,558,782
+169,291
+0.7% +$8.99M 0.7% 24
2015
Q2
$1.32B Buy
24,389,491
+42,776
+0.2% +$2.4M 0.75% 21
2015
Q1
$1.33B Buy
24,346,715
+761,708
+3% +$43.1M 0.76% 16
2014
Q4
$1.28B Buy
23,585,007
+738,746
+3% +$41.2M 0.76% 18
2014
Q3
$1.29B Sell
22,846,261
-315,392
-1% -$17.7M 0.84% 17
2014
Q2
$1.28B Sell
23,161,653
-488,461
-2% -$26.6M 0.83% 15
2014
Q1
$1.28B Buy
23,650,114
+445,790
+2% +$23.1M 0.86% 17
2013
Q4
$1.11B Buy
23,204,324
+1,301,785
+6% +$59.5M 0.77% 19
2013
Q3
$995M Buy
21,902,539
+45,006
+0.2% +$2.05M 0.8% 18
2013
Q2
$969M Buy
+21,857,533
New +$976M 0.85% 19

Other funds holding MRK

Geode Capital Management's MRK Position: Q1 2026 in Review

Geode Capital Management reduced its Merck (MRK) stake by 0.82% in Q1 2026, selling an estimated $56.6M and leaving 59,558,154 shares worth $7.14B. The position accounts for 0.44% of the portfolio, ranked #33.

Geode Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.43B in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Geode Capital Management held 59,558,154 shares of Merck worth $7.14B as of Q1 2026.
  • Geode Capital Management sold 489,830 Merck shares in Q1 2026, an estimated $56.6M.
  • Merck made up 0.44% of Geode Capital Management's portfolio in Q1 2026, its #33 holding.
  • Geode Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Merck position peaked at $7.43B in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.